Davenport & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $48.2M | Buy |
191,426
+10,268
| +6% | +$2.21M | 0.24% | 120 |
|
|
2026
Q1 | $39.4M | Sell |
181,158
-1,257
| -0.7% | -$279K | 0.21% | 116 |
|
|
2025
Q4 | $41.7M | Sell |
182,415
-5,545
| -3% | -$1.26M | 0.22% | 110 |
|
|
2025
Q3 | $43.5M | Sell |
187,960
-3,329
| -2% | -$678K | 0.23% | 107 |
|
|
2025
Q2 | $35.5M | Buy |
191,289
+4,968
| +3% | +$923K | 0.19% | 121 |
|
|
2025
Q1 | $39M | Buy |
186,321
+13,308
| +8% | +$2.59M | 0.23% | 109 |
|
|
2024
Q4 | $30.7M | Buy |
173,013
+1,759
| +1% | +$323K | 0.17% | 127 |
|
|
2024
Q3 | $33.8M | Sell |
171,254
-579
| -0.3% | -$108K | 0.19% | 124 |
|
|
2024
Q2 | $29.5M | Buy |
171,833
+549
| +0.3% | +$90.9K | 0.18% | 128 |
|
|
2024
Q1 | $31.2M | Sell |
171,284
-13,798
| -7% | -$2.38M | 0.19% | 130 |
|
|
2023
Q4 | $28.7M | Buy |
185,082
+2,794
| +2% | +$407K | 0.19% | 121 |
|
|
2023
Q3 | $27.2M | Sell |
182,288
-7,851
| -4% | -$1.15M | 0.21% | 115 |
|
|
2023
Q2 | $25.6M | Sell |
190,139
-2,804
| -1% | -$411K | 0.19% | 118 |
|
|
2023
Q1 | $30.7M | Sell |
192,943
-8,701
| -4% | -$1.33M | 0.24% | 110 |
|
|
2022
Q4 | $32.6M | Buy |
201,644
+3,752
| +2% | +$575K | 0.27% | 105 |
|
|
2022
Q3 | $26.6M | Buy |
197,892
+469
| +0.2% | +$67.3K | 0.23% | 109 |
|
|
2022
Q2 | $30.2M | Sell |
197,423
-4,703
| -2% | -$719K | 0.25% | 108 |
|
|
2022
Q1 | $32.8M | Buy |
202,126
+2,844
| +1% | +$413K | 0.22% | 103 |
|
|
2021
Q4 | $27M | Buy |
199,282
+21,588
| +12% | +$2.55M | 0.18% | 114 |
|
|
2021
Q3 | $19.2M | Buy |
177,694
+42,478
| +31% | +$4.85M | 0.14% | 126 |
|
|
2021
Q2 | $15.2M | Buy |
135,216
+22,528
| +20% | +$2.54M | 0.12% | 137 |
|
|
2021
Q1 | $12.2M | Buy |
112,688
+9,109
| +9% | +$974K | 0.11% | 128 |
|
|
2020
Q4 | $11.1M | Buy |
103,579
+1,651
| +2% | +$159K | 0.11% | 129 |
|
|
2020
Q3 | $8.93M | Sell |
101,928
-3,116
| -3% | -$293K | 0.1% | 130 |
|
|
2020
Q2 | $10.3M | Buy |
105,044
+11,942
| +13% | +$1.05M | 0.13% | 118 |
|
|
2020
Q1 | $7.09M | Buy |
93,102
+14,614
| +19% | +$1.24M | 0.1% | 125 |
|
|
2019
Q4 | $6.95M | Sell |
78,488
-616
| -0.8% | -$51.1K | 0.07% | 145 |
|
|
2019
Q3 | $5.75M | Buy |
79,104
+188
| +0.2% | +$12.9K | 0.07% | 154 |
|
|
2019
Q2 | $5.74M | Sell |
78,916
-1,968
| -2% | -$155K | 0.07% | 151 |
|
|
2019
Q1 | $6.52M | Sell |
80,884
-8,600
| -10% | -$704K | 0.08% | 138 |
|
|
2018
Q4 | $8.25M | Sell |
89,484
-3,686
| -4% | -$324K | 0.11% | 127 |
|
|
2018
Q3 | $8.81M | Sell |
93,170
-8,451
| -8% | -$801K | 0.1% | 130 |
|
|
2018
Q2 | $9.41M | Buy |
101,621
+1,787
| +2% | +$175K | 0.12% | 124 |
|
|
2018
Q1 | $9.45M | Sell |
99,834
-33,403
| -25% | -$3.67M | 0.12% | 121 |
|
|
2017
Q4 | $12.9M | Sell |
133,237
-2,392
| -2% | -$225K | 0.15% | 118 |
|
|
2017
Q3 | $12.1M | Sell |
135,629
-6,008
| -4% | -$457K | 0.15% | 116 |
|
|
2017
Q2 | $10.3M | Buy |
141,637
+29,502
| +26% | +$1.98M | 0.14% | 118 |
|
|
2017
Q1 | $7.02M | Sell |
112,135
-877
| -0.8% | -$55.1K | 0.1% | 134 |
|
|
2016
Q4 | $7.08M | Sell |
113,012
-8,541
| -7% | -$521K | 0.1% | 129 |
|
|
2016
Q3 | $7.67M | Buy |
121,553
+17,780
| +17% | +$1.15M | 0.11% | 121 |
|
|
2016
Q2 | $6.42M | Buy |
103,773
+7,433
| +8% | +$453K | 0.1% | 132 |
|
|
2016
Q1 | $5.5M | Sell |
96,340
-1,282
| -1% | -$71.5K | 0.09% | 135 |
|
|
2015
Q4 | $5.78M | Buy |
97,622
+19,458
| +25% | +$1.12M | 0.09% | 132 |
|
|
2015
Q3 | $4.25M | Buy |
78,164
+2,572
| +3% | +$167K | 0.07% | 150 |
|
|
2015
Q2 | $5.08M | Sell |
75,592
-1,517
| -2% | -$99K | 0.08% | 148 |
|
|
2015
Q1 | $4.51M | Buy |
77,109
+6,851
| +10% | +$414K | 0.07% | 161 |
|
|
2014
Q4 | $4.6M | Sell |
70,258
-19,998
| -22% | -$1.26M | 0.07% | 151 |
|
|
2014
Q3 | $5.21M | Sell |
90,256
-3,891
| -4% | -$216K | 0.09% | 140 |
|
|
2014
Q2 | $5.31M | Buy |
94,147
+705
| +0.8% | +$37K | 0.09% | 142 |
|
|
2014
Q1 | $4.8M | Sell |
93,442
-1,992
| -2% | -$101K | 0.09% | 147 |
|
|
2013
Q4 | $5.04M | Sell |
95,434
-1,192
| -1% | -$58.6K | 0.09% | 140 |
|
|
2013
Q3 | $4.32M | Sell |
96,626
-3,615
| -4% | -$160K | 0.09% | 140 |
|
|
2013
Q2 | $4.14M | Buy |
+100,241
| New | +$4.38M | 0.09% | 132 |
|
Other funds holding ABBV
ECSS
ATO
Davenport & Co's ABBV Position: Q2 2026 in Review
Davenport & Co increased its AbbVie (ABBV) stake by 5.7% in Q2 2026, buying an estimated $2.21M and bringing the position to 191,426 shares worth $48.2M. The position accounts for 0.24% of the portfolio, ranked #120.
Davenport & Co first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Davenport & Co held 191,426 shares of AbbVie worth $48.2M as of Q2 2026.
- Davenport & Co bought 10,268 AbbVie shares in Q2 2026, an estimated $2.21M.
- AbbVie made up 0.24% of Davenport & Co's portfolio in Q2 2026, its #120 holding.
- Davenport & Co first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.